We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Vertebral Balloon System Enables Targeted Placement

By HospiMedica International staff writers
Posted on 18 Feb 2014
A minimally invasive vertebral augmentation system treats vertebral compression fractures (VCFs), while also promoting patient safety.

The AVAflex Vertebral Balloon System combines a curved vertebral augmentation needle and a vertebral balloon to enable targeted balloon placement across the midline of the vertebral body, followed by targeted cement placement for optimal fill, all through a single pedicle. More...
The curved needle is made from nitinol, a superelastic composite made of nickel and titanium. The ultraflexible qualities of nitinol allow the curved augmentation needle to target hard to reach areas in the vertebral body, allowing maneuverability and flexibility in creating a cavity in the vertebral body prior to balloon insertion.

The AVAmax vertebral balloon, in turn, allows the surgeon to perform kyphoplasty in areas where a larger balloon might prohibit the procedure. Each catheter contains a durable balloon filled with a contrast agent to aid visualization when creating a void in the vertebral body, as well as clearly defined marker bands on the shaft to help identify correct advancement and placement. A digital pressure monitor at the tip of the inflation syringe helps to monitor pressure levels. At the touch of a button, balloon pressure can be shown in either atmospheres or PSI.

An important feature of the system is that it allows bilateral fracture reduction using a unilateral pediclular approach. Access kits and inflation syringes are packaged single and sterile, minimizing waste and improving operational efficiency. The AVAflex Vertebral Balloon System is a product of CareFusion (San Diego, CA, USA), and has been approved by the US Food and Drug Administration (FDA).

“The unipedicular approach offers a less risky approach to the midline of a vertebral body,” said Allan Brook, MD, an interventional radiologist with Montefiore Medical Center (New York, NY, USA). “Having another tool that places the cavity in the desired location can improve the effectiveness of vertebral augmentation in less time and with less radiation.”

Kyphoplasty uses a two-step process of inserting of a balloon device into the compacted vertebrae to attempt to restore the vertebrae to a more normal shape. Subsequently, a cement-like material is injected into the space created by the balloon to retain the correction. By restoring the vertebrae to a more normal state, alignment of the spine may be improved.

Related Links:

CareFusion



Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Electric Bed
DIXION Intensive Care Bed
Absorbable Monofilament Mesh
Phasix Mesh
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.